Back to Candriam S.C.A. Candriam S.C.A.

VRDNVRDN
10 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in VIRIDIAN THERAPEUTICS INC

Candriam S.C.A. holds 1.7M shares of VRDN (VIRIDIAN THERAPEUTICS INC), worth $31.3M as of 2026-Q2. The position was increased (+139.9% shares). VRDN represents 0.1% of Candriam S.C.A.'s portfolio.

Current Value

$31.3M

Current Shares

1.7M

Total Value Change

+$26.4M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+139.9%
$31.3M0.1%$18.37
56
2026-Q1
Decreased
711,739
-9.3%
$13.9M0.1%$29.32
0
2025-Q4
Decreased
785,098
-8.7%
$24.4M0.1%$31.02
0
2025-Q3
Decreased
860,232
-0.2%
$18.6M0.1%$21.61
0
2025-Q2
Decreased
862,273
-2.1%
$12.1M0.1%$14.33
0
2025-Q1
Increased
880,430
+20.4%
$11.9M0.1%$14.44
33
2024-Q4
Decreased
731,221
-2.5%
$14M0.1%$19.54
0
2024-Q3
Unchanged
749,804
0.0%
$17.1M0.1%$23.33
0
2024-Q2
Increased
749,804
+167.8%
$9.8M0.1%$13.01
45
2024-Q1
New
280,000
-
$4.9M0.0%$17.51
37

Other major holders of VRDN: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used